The U.S. veterinary active pharmaceutical ingredients (API) manufacturing market was valued at USD 2.98 billion in 2024 and is projected to expand at a CAGR of 5.28% between 2025 and 2034. This trajectory highlights the rising demand for animal health solutions amid heightened regulatory scrutiny and supply chain restructuring. The U.S. is strengthening its position as a central hub for...
Deutsch 
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek